Clinical Practice Guideline: Ménière’s Disease

Watanabe Y Mizukoshi K Shojaku H Watanabe I Hinoki M Kitahara M . Epidemiological and clinical characteristics of Ménière’s disease in Japan. Acta Otolaryngol Suppl. 1995;519:206-210.

Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease. Otolaryngol Head Neck Surg. 1995;113(3):181-185.

Alford B; Committee on Hearing and Equilibrium. Report of Subcommittee on Equilibrium and Its Measurement. Ménière’s disease: criteria for diagnosis and evaluation of therapy for reporting. Trans Am Acad Ophthalmol Otolaryngol. 1972;76(6):1462-1464.

Pearson BW Brackmann DE . Committee on Hearing and Equilibrium guidelines for reporting treatment results in Ménière’s disease. Otolaryngol Head Neck Surg. 1985;93(5):579-581.

Lopez-Escamez JA Carey J Chung WH , et al. Diagnostic criteria for Ménière’s disease. J Vestib Res. 2015;25(1):1-7.

Goebel JA . 2015 Equilibrium Committee amendment to the 1995 AAO-HNS guidelines for the definition of Ménière’s disease. Otolaryngol Head Neck Surg. 2016;154(3):403-404.

Kitahara M . Concepts and diagnostic criteria of Ménière’s disease. In: Ménière’s Disease. Tokyo, Japan: Springer-Verlag; 1990:3-12.

Paparella MM Djalilian HR . Etiology, pathophysiology of symptoms, and pathogenesis of Ménière’s disease. Otolaryngol Clin North Am. 2002;35(3):529-545.

Semaan MT Megerian CA . Contemporary perspectives on the pathophysiology of Ménière’s disease: implications for treatment. Curr Opin Otolaryngol Head Neck Surg. 2010;18(5):392-398.

Schuknecht HF Gulya AJ . Endolymphatic hydrops: an overview and classification. Ann Otol Rhinol Laryngol Suppl. 1983;106:1-20.

Oberman BS Patel VA Cureoglu S Isildak H . The aetiopathologies of Ménière’s disease: a contemporary review. Acta Otorhinolaryngol Ital. 2017;4:250-263.

Merchant SN Adams JC Nadol JB Jr. Pathophysiology of Ménière’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol. 2005;26(1):74-81.

Silverstein H Smouha E Jones R . Natural history vs surgery for Ménière’s disease. Otolaryngol Head Neck Surg. 1989;100(1):6-16.

Havia M Kentala E Pyykko I . Prevalence of Ménière’s disease in general population of southern Finland. Otolaryngol Head Neck Surg. 2005;133(5):762-768.

Friberg U Stahle J Svedberg A . The natural course of Ménière’s disease. Acta Otolaryngol Suppl. 1984;406:72-77.

Moser M Ranacher G Wilmot TJ Golden GJ . A double-blind clinical trial of hydroxyethylrutosides in Ménière’s disease. J Laryngol Otol. 1984;98(3):265-272.

Postema RJ Kingma CM Wit HP Albers FW Van Der Laan BF . Intratympanic gentamicin therapy for control of vertigo in unilateral Ménière’s disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol. 2008;128(8):876-880.

Schmidt JT Huizing EH . The clinical drug trial in Ménière’s disease with emphasis on the effect of betahistine SR. Acta Otolaryngol Suppl. 1992;497:1-189.

Stokroos R Kingma H . Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière’s disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol. 2004;124(2):172-175.

Torok N . Old and new in Ménière disease. Laryngoscope. 1977;87(11):1870-1877.

James AL Burton MJ . Betahistine for Ménière’s disease or syndrome. Cochrane Database Syst Rev. 2001;(1):CD001873.

Thirlwall AS Kundu S . Diuretics for Ménière’s disease or syndrome. Cochrane Database Syst Rev. 2006;(3):CD003599.

Claes J Van de Heyning PH . A review of medical treatment for Ménière’s disease. Acta Otolaryngol Suppl. 2000;544:34-39.

Santos PM Hall RA Snyder JM Hughes LF Dobie RA . Diuretic and diet effect on Ménière’s disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines. Otolaryngol Head Neck Surg. 1993;109(4):680-689.

Konrad HR . Intractable vertigo—when not to operate. Otolaryngol Head Neck Surg. 1986;95(4):482-484.

Monsell EM Brackmann DE Linthicum FH Jr. Why do vestibular destructive procedures sometimes fail? Otolaryngol Head Neck Surg. 1988;99(5):472-479.

Wiet RJ Kazan R Shambaugh GE . An holistic approach to Ménière’s disease: medical and surgical management. Laryngoscope. 1981;91(10):1647-1656.

House JW Doherty JK Fisher LM Derebery MJ Berliner KI . Ménière’s disease: prevalence of contralateral ear involvement. Otol Neurotol. 2006;27(3):355-361.

Blakley BW Goebel J . The meaning of the word “vertigo.” Otolaryngol Head Neck Surg. 2001;125(3):147-150.

Harris JP Alexander TH . Current-day prevalence of Ménière’s syndrome. Audiol Neurootol. 2010;15(5):318-322.

Ricchetti-Masterson K Aldridge M Logie J Suppapanya N Cook SF . Exploring methods to measure the prevalence of Ménière’s disease in the US Clinformatics database, 2010-2012. Audiol Neurootol. 2016;21(3):172-177.

Celestino D Ralli G . Incidence of Ménière’s disease in Italy. Am J Otol. 1991;12(2):135-138.

Akagi H Yuen K Maeda Y , et al. Ménière’s disease in childhood. Int J Pediatr Otorhinolaryngol. 2001;61(3):259-264.

Meyerhoff WL Paparella MM Shea D . Ménière’s disease in children. Laryngoscope. 1978;88(9, pt 1):1504-1511.

Mizukoshi K Ino H Ishikawa K , et al. Epidemiological survey of definite cases of Ménière’s disease collected by the seventeen members of the Ménière’s Disease Research Committee of Japan in 1975-1976. Adv Otorhinolaryngol. 1979;25:106-111.

Wang C Wu CH Cheng PW Young YH . Pediatric Ménière’s disease. Int J Pediatr Otorhinolaryngol. 2018;105:16-19.

Pyykko I Nakashima T Yoshida T Zou J Naganawa S . Ménière’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open. 2013;3(2).

Shojaku H Watanabe Y Fujisaka M , et al. Epidemiologic characteristics of definite Ménière’s disease in Japan. ORL J Otorhinolaryngol Relat Spec. 2005;67(5):305-309.

Tyrrell JS Whinney DJ Ukoumunne OC Fleming LE Osborne NJ . Prevalence, associated factors, and comorbid conditions for Ménière’s disease. Ear Hear. 2014;35(4):e162-e169.

Van Esch BF Van Benthem PP Van Der Zaag-Loonen HJ Bruintjes TD . Age of onset of Ménière’s disease in the Netherlands: data from a specialised dizziness clinic. J Laryngol Otol. 2016;130(7):624-627.

Watanabe I . Ménière’s disease in males and females. Acta Otolaryngol. 1981;91(5-6):511-514.

Wladislavosky-Waserman P Facer GW Mokri B Kurland LT . Ménière’s disease: a 30-year epidemiologic and clinical study in Rochester, MN, 1951-1980. Laryngoscope. 1984;94(8):1098-1102.

Huppert D Strupp M Brandt T . Long-term course of Ménière’s disease revisited. Acta Otolaryngol. 2010;130(6):644-651.

Porter M Boothroyd RA . Symptom severity, social supports, coping styles, and quality of life among individuals’ diagnosed with Ménierè’s disease. Chronic Illn. 2015;11(4):256-266.

Cohen H Ewell LR Jenkins HA . Disability in Ménière’s disease. Arch Otolaryngol Head Neck Surg. 1995;121(1):29-33.

Kinney SE Sandridge SA Newman CW . Long-term effects of Ménière’s disease on hearing and quality of life. Am J Otol. 1997;18(1):67-73.

Bronstein AM Golding JF Gresty MA , et al. The social impact of dizziness in London and Siena. J Neurol. 2010;257(2):183-190.

Stephens D Pyykko I Varpa K Levo H Poe D Kentala E . Self-reported effects of Ménière’s disease on the individual’s life: a qualitative analysis. Otol Neurotol. 2010;31(2):335-338.

Agrawal Y Ward BK Minor LB . Vestibular dysfunction: prevalence, impact and need for targeted treatment. J Vestib Res. 2013;23(3):113-117.

Lin HW Bhattacharyya N . Impact of dizziness and obesity on the prevalence of falls and fall-related injuries. Laryngoscope. 2014;124(12):2797-2801.

Anderson JP Harris JP . Impact of Ménière’s disease on quality of life. Otol Neurotol. 2001;22(6):888-894.

Yardley L Dibb B Osborne G . Factors associated with quality of life in Ménière’s disease. Clin Otolaryngol Allied Sci. 2003;28(5):436-441.

Ware JE Jr Sherbourne CD . The MOS 36-item Short-Form Health Survey (SF-36). I: conceptual framework and item selection. Med Care. 1992;30(6):473-483.

Soderman AC Bagger-Sjoback D Bergenius J Langius A . Factors influencing quality of life in patients with Ménière’s disease, identified by a multidimensional approach. Otol Neurotol. 2002;23(6):941-948.

Arroll M Dancey CP Attree EA Smith S James T . People with symptoms of Ménière’s disease: the relationship between illness intrusiveness, illness uncertainty, dizziness handicap, and depression. Otol Neurotol. 2012;33(5):816-823.

Kirby SE Yardley L . Understanding psychological distress in Ménière’s disease: a systematic review. Psychol Health Med. 2008;13(3):257-273.

Lin HW Bhattacharyya N . Balance disorders in the elderly: epidemiology and functional impact. Laryngoscope. 2012;122(8):1858-1861.

Schappert SM Rechtsteiner EA . Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13. 2011;(169):1-38.

Grill E Strupp M Muller M Jahn K . Health services utilization of patients with vertigo in primary care: a retrospective cohort study. J Neurol. 2014;261(8):1492-1498.

Tyrrell J Whinney DJ Taylor T . The cost of Ménière’s disease: a novel multisource approach. Ear Hear. 2016;37(3):e202-e209.

Crowson MG Schulz K Parham K , et al. Ménière’s disease: a CHEER database study of local and regional patient encounter and procedure patterns. Otolaryngol Head Neck Surg. 2016;155(1):15-21.

Benecke H Agus S Kuessner D Goodall G Strupp M . The burden and impact of vertigo: findings from the REVERT patient registry. Front Neurol. 2013;4:136.

Pyykko I Manchaiah V Zou J Levo H Kentala E . Impact of Tumarkin attacks on complaints and work ability in Ménière’s disease. J Vestib Res. 2018;28(3-4):319-330.

Rosenfeld RM Shiffman RN Robertson P . Clinical practice guideline development manual, third edition: a quality-driven approach for translating evidence into action. Otolaryngol Head Neck Surg. 2013;148(1):S1-S55.

Shiffman RN Michel G Rosenfeld RM Davidson C . Building better guidelines with BRIDGE-Wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability. J Am Med Inform Assoc. 2012;19(1):94-101.

Shiffman RN Dixon J Brandt C , et al. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak. 2005;5:23.

Eddy D . A Manual for Assessing Health Practices and Designing Practice Policies: The Explicit Approach. Philadelphia, PA: American College of Physicians; 1992.

American Academy of Pediatrics Steering Committee on Quality Improvement and Management. Policy statement: classifying recommendations for clinical practice guidelines. Pediatrics. 2004;114(3):874-877.

Choudhry NK Stelfox HT Detsky AS . Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002;287(5):612-617.

Detsky AS . Sources of bias for authors of clinical practice guidelines. CMAJ. 2006;175(9):1033-1035.

Légaré F Thompson-Leduc P . Twelve myths about shared decision making. Patient Educ Couns. 2014;96(3):281-286.

Bisdorff A Von Brevern M Lempert T Newman-Toker DE . Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res. 2009;19(1-2):1-13.

Brantberg K Baloh RW . Similarity of vertigo attacks due to Ménière’s disease and benign recurrent vertigo, both with and without migraine. Acta Otolaryngol. 2011;131(7):722-727.

Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.

Lempert T Olesen J Furman J , et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22(4):167-172.

Atkinson M . Ménière’s original papers reprinted with an English translation together with commentaries and biographical sketch. Acta Otolaryngol Suppl (Stockh). 1961;162:1-78.

Strupp M Brandt T . Diagnosis and treatment of vertigo and dizziness. Deutsches Arzteblatt international. 2008;105(10):173-180.

Neuhauser HK Radtke A von Brevern M , et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006;67(6):1028-1033.

Baloh RW . Neurotology of migraine. Headache. 1997;37(10):615-621.

von Brevern M Zeise D Neuhauser H Clarke AH Lempert T . Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128(pt 2):365-374.

Polensek SH Tusa RJ . Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurootol. 2010;15(4):241-246.

Radtke A von Brevern M Neuhauser H Hottenrott T Lempert T . Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79(15):1607-1614.

Kruit MC van Buchem MA Launer LJ Terwindt GM Ferrari MD . Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia. 2010;30(2):129-136.

Koppen H Boele HJ Palm-Meinders IH , et al. Cerebellar function and ischemic brain lesions in migraine patients from the general population. Cephalalgia. 2017;37(2):177-190.

Cho SJ Kim BK Kim BS , et al. Vestibular migraine in multicenter neurology clinics according to the appendix criteria in the third beta edition of the International Classification of Headache Disorders. Cephalalgia. 2016;36(5):454-462.

Formeister EJ Rizk HG Kohn MA Sharon JD . The epidemiology of vestibular migraine: a population-based survey study. Otol Neurotol. 2018;39(8):1037-1044.

Van Ombergen A Van Rompaey V Van de Heyning P Wuyts F . Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol. 2015;36(1):133-138.

Shin CH Kim Y Yoo MH , et al. Management of Ménière’s disease: how does the coexistence of vestibular migraine affect outcomes? Otol Neurotol. 2019;40(5):666-673.

Ménière P . Congestions Cerebrales Apoplectiformes. Gaz Med Fr. 1861;16.

Ménière P . Maladies de L’Oreille Interne Offrant les Symptoms de la Congestion Cerebrales Apoplectiformes. Gaz Med Fr. 1861;16:88.

Ménière P . Nouveaux Documents Relatifs Aux Lesions de L’Oreille Interne Caracterisees Par des Symptoms de Congestions Cerebrales Apoplectiformes. Gaz Med Fr. 1861;16:239.

Jafek B Barcz D . The otologic evaluation. In: Northern JL , ed. Hear Dis. 3rd ed. Boston, MA: Allyn & Bacon; 1996.

Kelly EA Li B Adams ME . Diagnostic accuracy of tuning fork tests for hearing loss: a systematic review. Otolaryngol Head Neck Surg. 2018;159(2):220-230.

Harrison M Naftalin L . Ménière’s Disease: Mechanism and Management. Springfield, IL: Charles C Thomas; 1968.

James AL Thorp MA . Ménière’s disease. BMJ. 2007;2007:0505.

Schuknecht H . Pathology of the Ear. Vol 85. Cambridge, MA: Harvard University Press; 1974.

American Academy of Otolaryngology—Head and Neck Surgery Foundation. Position statement: red flags—warning of ear disease. https://www.entnet.org/content/position-statement-red-flags-warning-ear-disease. Published 2014. Accessed November 9, 2018.

Joint Commission. Strong MRI safety programs prevent safety events. https://www.jointcommission.org/assets/1/23/Quick_Safety_Issue_31_2017_MRI_safety.pdf. Published 2017. Accessed June 25, 2019.

Stachler RJ Chandrasekhar SS Archer SM , et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012;146(3):S1-S35.

Gizzi M Riley E Molinari S . The diagnostic value of imaging the patient with dizziness: a Bayesian approach. Arch Neurol. 1996;53(12):1299-1304.

Ahsan SF Standring R Osborn DA Peterson E Seidman M Jain R . Clinical predictors of abnormal magnetic resonance imaging findings in patients with asymmetric sensorineural hearing loss. JAMA Otolaryngol Head Neck Surg. 2015;141(5):451-456.

Margolis RH Saly GL . Asymmetric hearing loss: definition, validation, and prevalence. Otol Neurotol. 2008;29(4):422-431.

Agrawal Y Platz EA Niparko JK . Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999-2004. Arch Intern Med. 2008;168(14):1522-1530.

Chia EM Wang JJ Rochtchina E Cumming RR Newall P Mitchell P . Hearing impairment and health-related quality of life: the Blue Mountains Hearing Study. Ear Hear. 2007;28(2):187-195.

Perazella MA . Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol. 2009;4(2):461-469.

Crowson MG Rocke DJ Hoang JK Weissman JL Kaylie DM . Cost-effectiveness analysis of a non-contrast screening MRI protocol for vestibular schwannoma in patients with asymmetric sensorineural hearing loss. Neuroradiol. 2017;59(8):727-736.

Daniels RL Shelton C Harnsberger HR . Ultra high resolution nonenhanced fast spin echo magnetic resonance imaging: cost-effective screening for acoustic neuroma in patients with sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 1998;119(4):364-369.

Daniels RL Swallow C Shelton C Davidson HC Krejci CS Harnsberger HR . Causes of unilateral sensorineural hearing loss screened by high-resolution fast spin echo magnetic resonance imaging: review of 1,070 consecutive cases. Am J Otol. 2000;21(2):173-180.

Hentschel MA Kunst HPM Rovers MM Steens SCA . Diagnostic accuracy of high-resolution T2-weighted MRI vs contrast-enhanced T1-weighted MRI to screen for cerebellopontine angle lesions in symptomatic patients. Clin Otolaryngol. 2018;43(3):805-811.

Sedwick JD Gajewski BJ Prevatt AR Antonelli PJ . Magnetic resonance imaging in the search for retrocochlear pathology. Otolaryngol Head Neck Surg. 2001;124(6):652-655.

Abele TA Besachio DA Quigley EP , et al. Diagnostic accuracy of screening MR imaging using unenhanced axial CISS and coronal T2WI for detection of small internal auditory canal lesions. Am J Neuroradiol. 2014;35(12):2366-2370.

Valesano JC Carr CM Eckel LJ Carlson ML Lane JI . MRI screening of the internal auditory canal: is gadolinium necessary to detect intralabyrinthine schwannomas? Am J Otolaryngol. 2018;39(2):133-137.

Attye A Dumas G Tropres I , et al. Recurrent peripheral vestibulopathy: is MRI useful for the diagnosis of endolymphatic hydrops in clinical practice? Eur Radiol. 2015;25(10):3043-3049.

Barath K Schuknecht B Naldi AM Schrepfer T Bockisch CJ Hegemann SC . Detection and grading of endolymphatic hydrops in Ménière disease using MR imaging. Am J Neuroradiol. 2014;35(7):1387-1392.

Gürkov R Flatz W Louza J Strupp M Ertl-Wagner B Krause E . Herniation of the membranous labyrinth into the horizontal semicircular canal is correlated with impaired caloric response in Ménière’s disease. Otol Neurotol. 2012;33(8):1375-1379.

Kato M Sugiura M Shimono M , et al. Endolymphatic hydrops revealed by magnetic resonance imaging in patients with atypical Ménière’s disease. Acta Otolaryngol. 2013;133(2):123-129.

Wu Q Dai C Zhao M Sha Y . The correlation between symptoms of definite Ménière’s disease and endolymphatic hydrops visualized by magnetic resonance imaging. Laryngoscope. 2016;126(4):974-979.

Choi JE Kim YK Cho YS , et al. Morphological correlation between caloric tests and vestibular hydrops in Ménière’s disease using intravenous Gd enhanced inner ear MRI. PLoS One. 2017;12(11):e0188301.

Fiorino F Pizzini FB Beltramello A Barbieri F . MRI performed after intratympanic gadolinium administration in patients with Ménière’s disease: correlation with symptoms and signs. Eur Arch Otorhinolaryngol. 2011;268(2):181-187.

Fukuoka H Takumi Y Tsukada K , et al. Comparison of the diagnostic value of 3 T MRI after intratympanic injection of GBCA, electrocochleography, and the glycerol test in patients with Ménière’s disease. Acta Otolaryngol. 2012;132(2):141-145.

Fukuoka H Tsukada K Miyagawa M , et al. Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent (GBCA) administration with MRI for Ménière’s disease. Acta Otolaryngol. 2010;130(1):10-16.

Gu X Fang ZM Liu Y Huang ZW Zhang R Chen X . Diagnostic advantages of intratympanically gadolinium contrast-enhanced magnetic resonance imaging in patients with bilateral Ménière’s disease. Am J Otolaryngol. 2015;36(1):67-73.

Gürkov R Flatz W Louza J Strupp M Ertl-Wagner B Krause E . In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Ménière’s disease. Otol Neurotol. 2012;33(6):1040-1045.

Gurkov R Flatz W Louza J Strupp M Krause E . In vivo visualization of endolyphatic hydrops in patients with Ménière’s disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol. 2011;268(12):1743-1748.

Gurkov R Kantner C Strupp M Flatz W Krause E Ertl-Wagner B . Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms. Eur Arch Otorhinolaryngol. 2014;271(10):2661-2667.

Horii A Osaki Y Kitahara T , et al. Endolymphatic hydrops in Ménière’s disease detected by MRI after intratympanic administration of gadolinium: comparison with sudden deafness. Acta Otolaryngol. 2011;131(6):602-609.

Hornibrook J Flook E Greig S , et al. MRI inner ear imaging and tone burst electrocochleography in the diagnosis of Ménière’s disease. Otol Neurotol. 2015;36(6):1109-1114.

Ito T Kitahara T Inui H , et al. Endolymphatic space size in patients with Ménière’s disease and healthy controls. Acta Otolaryngol. 2016;136(9):879-882.

Jerin C Berman A Krause E Ertl-Wagner B Gürkov R . Ocular vestibular evoked myogenic potential frequency tuning in certain Ménière’s disease. Hear Res. 2014;310:54-59.

Katayama N Yamamoto M Teranishi M , et al. Relationship between endolymphatic hydrops and vestibular-evoked myogenic potential. Acta Otolaryngol. 2010;130(8):917-923.

Kato M Teranishi M Katayama N Sone M Naganawa S Nakashima T . Association between endolymphatic hydrops as revealed by magnetic resonance imaging and caloric response. Otol Neurotol. 2011;32(9):1480-1485.

Liu Y Jia H Shi J , et al. Endolymphatic hydrops detected by 3-dimensional fluid-attenuated inversion recovery MRI following intratympanic injection of gadolinium in the asymptomatic contralateral ears of patients with unilateral Ménière’s disease. Med Sci Monit. 2015;21:701-707.

Naganawa S Kawai H Taoka T , et al. Cochlear lymph fluid signal increase in patients with otosclerosis after intravenous administration of gadodiamide. Magn Reson Med Sci. 2016;15(3):308-315.

Okazaki Y Yoshida T Sugimoto S , et al. Significance of endolymphatic hydrops in ears with unilateral sensorineural hearing loss. Otol Neurotol. 2017;38(8):1076-1080.

Okumura T Imai T Takimoto Y , et al. Assessment of endolymphatic hydrops and otolith function in patients with Ménière’s disease. Eur Arch Otorhinolaryngol. 2017;274(3):1413-1421.

Seo YJ Kim J Choi JY Lee WS . Visualization of endolymphatic hydrops and correlation with audio-vestibular functional testing in patients with definite Ménière’s disease. Auris Nasus Larynx. 2013;40(2):167-172.

Shimono M Teranishi M Yoshida T , et al. Endolymphatic hydrops revealed by magnetic resonance imaging in patients with acute low-tone sensorineural hearing loss. Otol Neurotol. 2013;34(7):1241-1246.

Sun W Guo P Ren T Wang W . Magnetic resonance imaging of intratympanic gadolinium helps differentiate vestibular migraine from Ménière disease. Laryngoscope. 2017;127(10):2382-2388.

Tagaya M Yamazaki M Teranishi M , et al. Endolymphatic hydrops and blood-labyrinth barrier in Ménière’s disease. Acta Otolaryngol. 2011;131(5):474-479.

Teranishi M Naganawa S Katayama N , et al. Image evaluation of endolymphatic space in fluctuating hearing loss without vertigo. Eur Arch Otorhinolaryngol. 2009;266(12):1871-1877.

Yamamoto M Teranishi M Naganawa S , et al. Relationship between the degree of endolymphatic hydrops and electrocochleography. Audiol Neurootol. 2010;15(4):254-260.

Yoshida T Teranishi M Kato M , et al. Endolymphatic hydrops in patients with tinnitus as the major symptom. Eur Arch Otorhinolaryngol. 2013;270(12):3043-3048.

Attye A Eliezer M Boudiaf N , et al. MRI of endolymphatic hydrops in patients with Ménière’s disease: a case-controlled study with a simplified classification based on saccular morphology. Eur Radiol. 2017;27(8):3138-3146.

Fang ZM Chen X Gu X , et al. A new magnetic resonance imaging scoring system for perilymphatic space appearance after intratympanic gadolinium injection, and its clinical application. J Laryngol Otol. 2012;126(5):454-459.

Homann G Vieth V Weiss D , et al. Semi-quantitative vs volumetric determination of endolymphatic space in Ménière’s disease using endolymphatic hydrops 3T-HR-MRI after intravenous gadolinium injection. PLoS One. 2015;10(3):e0120357.

Imai T Uno A Kitahara T , et al. Evaluation of endolymphatic hydrops using 3-T MRI after intravenous gadolinium injection. Eur Arch Otorhinolaryngol. 2017;274(12):4103-4111.

Naganawa S Suzuki K Nakamichi R , et al. Semi-quantification of endolymphatic size on MR imaging after intravenous injection of single-dose gadodiamide: comparison between two types of processing strategies. Magn Reson Med Sci. 2013;12(4):261-269.

Nakashima T Naganawa S Pyykko I , et al. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl. 2009;(560):5-8.

Suga K Kato M Yoshida T , et al. Changes in endolymphatic hydrops in patients with Ménière’s disease treated conservatively for more than 1 year. Acta Otolaryngol. 2015;135(9):866-870.

Fiorino F Mattellini B Vento M Mazzocchin L Bianconi L Pizzini FB . Does the intravenous administration of frusemide reduce endolymphatic hydrops? J Laryngol Otol. 2016;130(3):242-247.

Gurkov R Flatz W Keeser D Strupp M Ertl-Wagner B Krause E . Effect of standard-dose betahistine on endolymphatic hydrops: an MRI pilot study. Eur Arch Otorhinolaryngol. 2013;270(4):1231-1235.

Sepahdari AR Vorasubin N Ishiyama G Ishiyama A . endolymphatic hydrops reversal following acetazolamide therapy: demonstration with delayed intravenous contrast-enhanced 3D-FLAIR MRI. Am J Neuroradiol. 2016;37(1):151-154.

Claes G Van den Hauwe L Wuyts F Van de Heyning P . Does intratympanic gadolinium injection predict efficacy of gentamicin partial chemolabyrinthectomy in Ménière’s disease patients? Eur Arch Otorhinolaryngol. 2012;269(2):413-418.

Fiorino F Pizzini FB Barbieri F Beltramello A . Variability in the perilymphatic diffusion of gadolinium does not predict the outcome of intratympanic gentamicin in patients with Ménière’s disease. Laryngoscope. 2012;122(4):907-911.

Fiorino F Pizzini FB Barbieri F Beltramello A . Magnetic resonance imaging fails to show evidence of reduced endolymphatic hydrops in gentamicin treatment of Ménière’s disease. Otol Neurotol. 2012;33(4):629-633.

Liu F Huang W Chen Q Meng X Wang Z He Y . Noninvasive evaluation of the effect of endolymphatic sac decompression in Ménière’s disease using magnetic resonance imaging. Acta Otolaryngol. 2014;134(7):666-671.

Liu IY Sepahdari AR Ishiyama G Ishiyama A . High resolution MRI shows presence of endolymphatic hydrops in patients still symptomatic after endolymphatic shunt surgery. Otol Neurotol. 2016;37(8):1128-1130.

Uno A Imai T Watanabe Y , et al. Changes in endolymphatic hydrops after sac surgery examined by Gd-enhanced MRI. Acta Otolaryngol. 2013;133(9):924-929.

Zhang Y Cui YH Hu Y , et al. Changes in endolymphatic hydrops visualized by magnetic resonance imaging after sac surgery. J Huazhong Univ Sci Technolog Med Sci. 2016;36(5):736-740.

Shellock F . Reference Manual for Magnetic Resonance Saftey, Implants, and Devices. Playa Del Rey, CA: Biomedical Research Publishing Group; 2018.

US Food and Drug Administration. FDA drug safety communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-gadolinium-based-contrast-agents-gbcas-are-retained-body. Published 2018. Accessed June 25, 2019.

US Food and Drug Administration. Magnevist for Intravenous Administration. Washington, DC: US Food and Drug Administration; 2013.

Adams ME Heidenreich KD Kileny PR . Audiovestibular testing in patients with Ménière’s disease. Otolaryngol Clin North Am. 2010;43(5):995-1009.

Adams ME Marmor S Yueh B Kane RL . Geographic variation in use of vestibular testing among Medicare beneficiaries. Otolaryngol Head Neck Surg. 2017;156(2):312-320.

Piker EG Schulz K Parham K , et al. Variation in the use of vestibular diagnostic testing for patients presenting to otolaryngology clinics with dizziness. Otolaryngol Head Neck Surg. 2016;155(1):42-47.

Phillips JS Mallinson AI Hamid MA . Cost-effective evaluation of the vestibular patient. Curr Opin Otolaryngol Head Neck Surg. 2011;19(5):403-409.

Kelly EA Stocker C Kempton C Dierking D Fehlberg H Adams M . Vestibular testing: patient perceptions, morbidity and opporunity costs. Otol Neurotol. 2018;39(10):1222-1228.

Ferraro JA Durrant JD . Electrocochleography in the evaluation of patients with Ménière’s disease/endolymphatic hydrops. J Am Acad Audiol. 2006;17(1):45-68.

Foster CA Breeze RE . Endolymphatic hydrops in Ménière’s disease: cause, consequence, or epiphenomenon? Otol Neurotol. 2013;34(7):1210-1214.

Wuyts FL Van De Heyning PH Van Spaendonck MP Molenberghs G . A review of electrocochleography: instrumentation settings and meta-analysis of criteria for diagnosis of endolymphatic hydrops. Acta Otolaryngol. 1997;117(suppl 526):14-20.

Ziylan F Smeeing DP Stegeman I Thomeer HG . Click stimulus electrocochleography versus MRI with intratympanic contrast in Ménière’s disease: a systematic review. Otol Neurotol. 2016;37(5):421-427.

Iseli C Gibson W . A comparison of three methods of using transtympanic electrocochleography for the diagnosis of Ménière’s disease: click summating potential measurements, tone burst summating potential amplitude measurements, and biasing of the summating potential using a low frequency tone. Acta Otolaryngol. 2010;130(1):95-101.

Al-momani MO Ferraro JA Gajewski BJ Ator G . Improved sensitivity of electrocochleography in the diagnosis of Ménière’s disease. Int J Audiol. 2009;48(11):811-819.

Ikino CM de Almeida ER . Summating potential-action potential waveform amplitude and width in the diagnosis of Ménière’s disease. Laryngoscope. 2006;116(10):1766-1769.

Arts HA Adams ME Telian SA El-Kashlan H Kileny PR . Reversible electrocochleographic abnormalities in superior canal dehiscence. Otol Neurotol. 2009;30(1):79-86.

Cordero-Yanza JA Arrieta Vazquez EV Hernaiz Leonardo JC Mancera Sanchez J Hernandez Palestina MS Perez-Fernandez N . Comparative study between the caloric vestibular and the video-head impulse tests in unilateral Ménière’s disease. Acta Otolaryngol. 2017;137(11):1178-1182.

Lee SU Kim HJ Koo JW Kim JS . Comparison of caloric and head-impulse tests during the attacks of Ménière’s disease. Laryngoscope. 2017;127(3):702-708.

Shin JE Kim CH Park HJ . Vestibular abnormality in patients with Ménière’s disease and migrainous vertigo. Acta Otolaryngol. 2013;133(2):154-158.

McGarvie LA Curthoys IS MacDougall HG Halmagyi GM . What does the dissociation between the results of video head impulse versus caloric testing reveal about the vestibular dysfunction in Ménière’s disease? Acta Otolaryngol. 2015;135(9):859-865.

McCaslin D Rivas A Jacobson G Bennett M . The dissociation of video head impulse test (vHIT) and bithermal caloric test results provide topological localization of vestibular system impairment in patients with “definitie” Ménière’s disease. Am J Audiol. 2015;24:1-10.

Ahmed MF Goebel JA Sinks BC . Caloric test versus rotational sinusoidal harmonic acceleration and step-velocity tests in patients with and without suspected peripheral vestibulopathy. Otol Neurotol. 2009;30(6):800-805.

Slattery EL Sinks BC Goebel JA . Vestibular tests for rehabilitation: applications and interpretation. NeuroRehabilitation. 2011;29(2):143-151.

Fife TD Colebatch JG Kerber KA , et al. Practice guideline: cervical and ocular vestibular evoked myogenic potential testing. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2017;89(22):2288-2296.

Zhang S Leng Y Liu B Shi H Lu M Kong W . Diagnostic value of vestibular evoked myogenic potentials in endolymphatic hydrops: a meta-analysis. Sci Rep. 2015;5:14951-14951.

Tabet P Saliba I . Ménière’s disease and vestibular migraine: updates and review of the literature. J Clin Med Res. 2017;9(9):733-744.

Lin MY Timmer FC Oriel BS , et al. Vestibular evoked myogenic potentials (VEMP) can detect asymptomatic saccular hydrops. Laryngoscope. 2006;116(6):987-992.

Lucieer F Duijn S Van Rompaey V , et al. Full spectrum of reported symptoms of bilateral vestibulopathy needs further investigation—a systematic review. Front Neurol. 2018;9:352-352.

Gode S Celebisoy N Akyuz A , et al. Single-shot, low-dose intratympanic gentamicin in Ménière disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome. Am J Otolaryngol. 2011;32(5):412-416.

Coulter A Ellins J . Effectiveness of strategies for informing, educating, and involving patients. BMJ. 2007;335(7609):24-27.

Institute of Medicine Committee on Health Literacy. Health Literacy: A Prescription to End Confusion. Washington, DC: National Academies Press; 2004.

O’Connor AM Bennett CL Stacey D , et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;(3):CD001431.

Gravel K Legare F Graham ID . Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals’ perceptions. Implement Sci. 2006;1:16.

Stacey D Légaré F Lewis K , et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;(4):CD001431.

Yardley L Kirby S . Evaluation of booklet-based self-management of symptoms in Ménière disease: a randomized controlled trial. Psychosom Med. 2006;68(5):762-769.

Lin GA Fagerlin A . Shared decision making: state of the science. Circ Cardiovasc Qual Outcomes. 2014;7(2):328-334.

Brandt T Zwergal A Strupp M . Medical treatment of vestibular disorders. Expert Opin Pharmacother. 2009;10(10):1537-1548.

Hain TC Yacovino D . Pharmacologic treatment of persons with dizziness. Neurol Clin. 2005;23(3):831-853.

Lin E Aligene K . Pharmacology of balance and dizziness. NeuroRehabilitation. 2013;32(3):529-542.

Amini A Heidari K Asadollahi S , et al. Intravenous promethazine versus lorazepam for the treatment of peripheral vertigo in the emergency department: a double blind, randomized clinical trial of efficacy and safety. J Vestib Res. 2014;24(1):39-47.

Marill KA Walsh MJ Nelson BK . Intravenous lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial. Ann Emerg Med. 2000;36(4):310-319.

Shih RD Walsh B Eskin B , et al. Diazepam and meclizine are equally effective in the treatment of vertigo: an emergency department randomized double-blind placebo-controlled trial. J Emerg Med. 2017;52(1):23-27.

Kurko TA Saastamoinen LK Tahkapaa S , et al. Long-term use of benzodiazepines: definitions, prevalence and usage patterns—a systematic review of register-based studies. Eur Psychiatry. 2015;30(8):1037-1047.

Schonmann Y Goren O Bareket R Comaneshter D Cohen AD Vinker S . Chronic hypnotic use at 10 years-does the brand matter? Eur J Clin Pharmacol. 2018;74(12):1623-1631.

Storper IS Spitzer JB Scanlan M . Use of glycopyrrolate in the treatment of Ménière’s disease. Laryngoscope. 1998;108(10):1442-1445.

Clissold SP Heel RC . Transdermal hyoscine (Scopolamine): a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985;29(3):189-207.

Hahn A Sejna I Stefflova B Schwarz M Baumann W . A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders: a randomized, reference-controlled clinical study. Clin Drug Investig. 2008;28(2):89-99.

Pytel J Nagy G Toth A Spellenberg S Schwarz M Repassy G . Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study. Clin Ther. 2007;29(1):84-98.

Stahle J . Medical treatment of fluctuant hearing loss in Ménière’s disease. Am J Otol. 1984;5(6):529-533.

Wright T . Ménière’s disease. BMJ Clin Evid. 2015;2015.

Acharya A Singh M Shrestha A . First line treatment of Ménière’s disease. J Lumbini Med Coll. 2016;4(2):68-71.

Sanchez-Sellero I San-Roman-Rodriguez E Santos-Perez S Rossi-Izquierdo M Soto-Varela A . Caffeine intake and Ménière’s disease: is there relationship? Nutr Neurosci. 2018;21(9):624-631.

Sánchez-Sellero I San-Román-Rodríguez E Santos-Pérez S Rossi-Izquierdo M Soto-Varela A . Alcohol consumption in Ménière’s disease patients. Nutr Neurosci. 2018;23(1):68-74.

Luxford E Berliner KI Lee J Luxford WM . Dietary modification as adjunct treatment in Ménière’s disease: patient willingness and ability to comply. Otol Neurotol. 2013;34(8):1438-1443.

Miyashita T Inamoto R Fukuda S , et al. Hormonal changes following a low-salt diet in patients with Ménière’s disease. Auris Nasus Larynx. 2017;44(1):52-57.

Cogswell ME Zhang Z Carriquiry AL , et al. Sodium and potassium intakes among US adults: NHANES 2003-2008. Am J Clin Nutr. 2012;96(3):647-657.

Derebery MJ . Allergic management of Ménière’s disease: an outcome study. Otolaryngol Head Neck Surg. 2000;122(2):174-182.

Sen P Georgalas C Papesch M . Co-morbidity of migraine and Ménière’s disease—is allergy the link? J Laryngol Otol. 2005;119(6):455-460.

Banks C McGinness S Harvey R Sacks R . Is allergy related to Ménière’s disease? Curr Allergy Asthma Rep. 2012;12:255-260.

Weinreich HM Agrawal Y . The link between allergy and Ménière’s disease. Curr Opin Otolaryngol Head Neck Surg. 2014;22(3):227-230.

Radtke A Lempert T Gresty MA Brookes GB Bronstein AM Neuhauser H . Migraine and Ménière’s disease: is there a link? Neurology. 2002;59(11):1700-1704.

Mehle M . Migraine and allergy: a review and clinical update. Curr Allergy Asthma Rep. 2012;12:240-245.

Kitahara T Doi K Maekawa C , et al. Ménière’s attacks occur in the inner ear with excessive vasopressin type-2 receptors. J Neuroendocrinol. 2008;20(12):1295-1300.

Maekawa C Kitahara T Kizawa K , et al. Expression and translocation of aquaporin-2 in the endolymphatic sac in patients with Ménière’s disease. J Neuroendocrinol. 2010;22(11):1157-1164.

Kitahara T Okamoto H Fukushima M , et al. A two-year randomized trial of interventions to decrease stress hormone vasopressin production in patients with Ménière’s disease—a pilot study. PLoS One. 2016;11(6):e0158309.

He J Jiang L Peng T Xia M Chen H . Acupuncture points stimulation for Ménière’s disease/syndrome: a promising therapeutic approach. Evid Based Complement Alternat Med. 2016;2016:10.

Long AF Xing M Morgan K Brettle A . Exploring the evidence base for acupuncture in the treatment of Ménière’s syndrome—a systematic review. Evid Based Complement Alternat Med. 2011;2011:429102.

Sun Y-X Wang Y Ji X , et al. A randomized trial of Chinese Diaoshi Jifa on treatment of dizziness in Ménière’s disease. Evid Based Complement Alt Med. 2014;2014:7.

Hallpike CS Cairns H . Observations on the pathology of Ménière’s syndrome: section of otology. Proc R Soc Med. 1938;31(11):1317-1336.

Yamakawa K Naito K . Hearing organ of a patient who showed Ménière’s symptoms [in Japanese]. J Otolaryngol Soc Jpn. 1938;44:2310-2312.

Adour KK Byl FM Hilsinger RL Jr Wilcox RD . Ménière’s disease as a form of cranial polyganglionitis. Laryngoscope. 1980;90(3):392-398.

Lempert J Wolff D Rambo JH Wever EG Lawrence M . New theory for the correlation of the pathology and the symptomatology of Ménière’s disease; a research study of the vestibular endolymphatic labyrinth. Trans Am Otol Soc. 1952;40:53-82.

Vrabec JT . Herpes simplex virus and Ménière’s disease. Laryngoscope. 2003;113(9):1431-1438.

Salt AN DeMott JE . Ionic and potential changes of the endolymphatic sac induced by endolymph volume changes. Hear Res. 2000;149(1-2):46-54.

Sziklai I Ferrary E Horner KC Sterkers O Amiel C . Time-related alteration of endolymph composition in an experimental model of endolymphatic hydrops. Laryngoscope. 1992;102(4):431-438.

Brown M . Ménière’s syndrome. Arch Neurol Psychitary. 1941;46:561-565.

Morrison AW . Anticipation in Ménière’s disease. J Laryngol Otol. 1995;109(6):499-502.

Morrison AW Mowbray JF Williamson R Sheeka S Sodha N Koskinen N . On genetic and environmental factors in Ménière’s disease. Am J Otol. 1994;15(1):35-39.

Dederding D . Clinical and experimental examinations in patients suffering from Mb Meniegri including a study of the problem of bone conduction. Acta Otolaryngol. 1929;13:5-213.

Furstenberg AC Lashmet FH Lathrop F . Ménière’s symptom complex: medical treatment. Ann Otol Rhinol Laryngol. 1992;101(1):20-31.

Arnold W Altermatt HJ Gebbers JO Laissue J . Secretory immunoglobulin A in the human endolymphatic sac: an immunohistochemical study. ORL J Otorhinolaryngol Relat Spec. 1984;46(6):286-288.

Arnold W Pfaltz R Altermatt H-J . Evidence of serum antibodies against inner ear tissues in the blood of patients with certain sensorineural hearing disorders. Acta Otolaryngol. 1985;99(3-4):437-444.

Brookes G . Circulating immune complexes in Ménière’s disease. Arch Otolaryngol Head Neck Surg. 1986;112(5):536-540.

Derebery MJ Rao VS Siglock TJ Linthicum FH Nelson RA . Ménière’s disease: an immune complex-mediated illness? Laryngoscope. 1991;101(3):225-229.

Seymour JC . The ætiology, pathology and conservative surgical treatment of Ménière’s disease. J Laryngol Otol. 1960;74(9):599-627.

Duke W . Ménière’s syndrome caused by allergy. JAMA. 1923;81:2179-2181.

Williams H . Allergy of the inner ear (Ménière’s disease). Am Arch Otolaryngol. 1952;56:24-44.

Crowson MG Patki A Tucci DL . A systematic review of diuretics in the medical management of Ménière’s disease. Otolaryngol Head Neck Surg. 2016;154(5):824-834.

Laurent S . Antihypertensive drugs. Pharmacol Res. 2017;124:116-125.

Klockhoff I Lindblom U . Ménière’s disease and hydrochlorothiazide (Dichlotride)—a critical analysis of symptoms and therapeutic effects. Acta Otolaryngol. 1967;63(4):347-365.

van Deelen GW Huizing EH . Use of a diuretic (Dyazide) in the treatment of Ménière’s disease: a double-blind cross-over placebo-controlled study. ORL J Otorhinolaryngol Relat Spec. 1986;48(5):287-292.

Sharon JD Trevino C Schubert MC Carey JP . Treatment of Ménière’s disease. Curr Treat Options Neurol. 2015;17(4):341.

Arrang JM Garbarg M Quach TT Dam Trung Tuong M Yeramian E Schwartz JC . Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol. 1985;111(1):73-84.

Gbahou F Davenas E Morisset S Arrang JM . Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol Exp Ther. 2010;334(3):945-954.

Murdin L Hussain K Schilder AGM . Betahistine for symptoms of vertigo. Cochrane Database Syst Rev. 2016(6):CD010696.

Adrion C Fischer CS Wagner J Gurkov R Mansmann U Strupp M . Efficacy and safety of betahistine treatment in patients with Ménière’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016;352:h6816.

Ramos Alcocer R Ledezma Rodriguez JG Navas Romero A , et al. Use of betahistine in the treatment of peripheral vertigo. Acta Otolaryngol. 2015;135(12):1205-1211.

Nauta JJ . Meta-analysis of clinical studies with betahistine in Ménière’s disease and vestibular vertigo. Eur Arch Otorhinolaryngol. 2014;271(5):887-897.

Morales-Luckie E Cornejo-Suarez A Zaragoza-Contreras MA Gonzalez-Perez O . Oral administration of prednisone to control refractory vertigo in Ménière’s disease: a pilot study. Otol Neurotol. 2005;26(5):1022-1026.

Fisher LM Derebery MJ Friedman RA . Oral steroid treatment for hearing improvement in Ménière’s disease and endolymphatic hydrops. Otol Neurotol. 2012;33(9):1685-1691.

Gacek RR . Recovery of hearing in Ménière’s disease after antiviral treatment. Am J Otolaryngol. 2015;36(3):315-323.

Meniett device. http://meniett.com/. Published 2016. Accessed November 9, 2018.

Syed MI Rutka JA Hendry J Browning GG . Positive pressure therapy for Ménière’s syndrome/disease with a Meniett device: a systematic review of randomised controlled trials. Clin Otolaryngol. 2015;40(3):197-207.

van Sonsbeek S Pullens B van Benthem PP . Positive pressure therapy for Ménière’s disease or syndrome. Cochrane Database Syst Rev. 2015;(3):CD008419.

Gürkov R Filipe Mingas LB Rader T Louza J Olzowy B Krause E . Effect of transtympanic low-pressure therapy in patients with unilateral Ménière’s disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial. J Laryngol Otol. 2012;126(4):356-362.

Gates GA Verrall A Green JD Jr Tucci DL Telian SA . Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg. 2006;132(12):1311-1316.

Ahsan SF Standring R Wang Y . Systematic review and meta-analysis of Meniett therapy for Ménière’s disease. Laryngoscope. 2015;125(1):203-208.

Zhang SL Leng Y Liu B Shi H Lu M Kong WJ . Meniett therapy for Ménière’s disease: an updated meta-analysis. Otol Neurotol. 2016;37(3):290-298.

Ogawa Y Otsuka K Hagiwara A , et al. Clinical study of tympanostomy tube placement for patients with intractable Ménière’s disease. J Laryngol Otol. 2015;129(2):120-125.

Sugawara K Kitamura K Ishida T Sejima T . Insertion of tympanic ventilation tubes as a treating modality for patients with Ménière’s disease: a short- and long-term follow-up study in seven cases. Auris Nasus Larynx. 2003;30(1):25-28.

Itoh A Sakata E . Treatment of vestibular disorders. Acta Otolaryngol. 1991;111(suppl 481):617-623.

Bertlich M Ihler F Sharaf K Weiss BG Strupp M Canis M . Betahistine metabolites, aminoethylpyridine, and hydroxyethylpyridine increase cochlear blood flow in guinea pigs in vivo. Int J Audiol. 2014;53(10):753-759.

Kim SH Marcus DC . Regulation of sodium transport in the inner ear. Hear Res. 2011;280(1-2):21-29.

Long DS Smith ML Pries AR Ley K Damiano ER . Microviscometry reveals reduced blood viscosity and altered shear rate and shear stress profiles in microvessels after hemodilution. Proc Natl Acad Sci U S A. 2004;101(27):10060-10065.

Otake H Yamamoto H Teranishi M Sone M Nakashima T . Cochlear blood flow during occlusion and reperfusion of the anterior inferior cerebellar artery—effect of topical application of dexamethasone to the round window. Acta Otolaryngol. 2009;129(2):127-131.

Pondugula S Sanneman J Wangemann P Milhaud P Marcus D . Glucocorticoids stimulate cation absorption by semicircular canal duct epithelium via epithelial sodium channel. Am J Physiol Renal Physiol. 2004;286(6):F1127-F1135.

Shirwany NA Seidman MD Tang W . Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol. 1998;19(2):230-235.

Trune DR Kempton JB Gross ND . Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res. 2006;212(1-2):22-32.

Trune DR Kempton JB Kessi M . Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice. Laryngoscope. 2000;110(11):1902-1906.

Casani AP Piaggi P Cerchiai N Seccia V Franceschini SS Dallan I . Intratympanic treatment of intractable unilateral Ménière disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg. 2012;146(3):430-437.

ElBeltagy Y Shafik A Mahmoud A Hazaa N . Intratympanic injection in Ménière’s disease; symptomatic and audiovestibular; comparative, prospective randomized 1-year control study. Egypt J Otolaryngol. 2012;28(3):171-183.

Patel M Agarwal K Arshad Q , et al. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière’s disease: a randomised, double-blind, comparative effectiveness trial. Lancet. 2016;388(10061):2753-2762.

Sarafraz M Saki N Nikakhlagh S Mashali L Arad A . Comparison the efficacy of intratympanic injections of methylprednisolone and gentamicin to control vertigo in unilateral Ménière’s disease. Biomed Pharmacol J. 2015;8:705-709.

Silverstein H Isaacson JE Olds MJ Rowan PT Rosenberg S . Dexamethasone inner ear perfusion for the treatment of Ménière’s disease: a prospective, randomized, double-blind, crossover trial. Am J Otol. 1998;19(2):196-201.

Syed MI Ilan O Nassar J Rutka JA . Intratympanic therapy in Ménière’s syndrome or disease: up to date evidence for clinical practice. Clin Otolaryngol. 2015;40(6):682-690.

Lavigne P Lavigne F Saliba I . Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol. 2016;273(9):2271-2278.

Patel M . Intratympanic corticosteroids in Ménière’s disease: a mini-review. J Otol. 2017;12(3):117-124.

Paragache G Panda NK Ragunathan M Sridhara . Intratympanic dexamethasone application in Ménière’s disease—is it superior to conventional therapy? Indian J Otolaryngol Head Neck Surg. 2005;57(1):21-23.

Phillips JS Westerberg B . Intratympanic steroids for Ménière’s disease or syndrome. Cochrane Database Syst Rev. 2011;(7):CD008514.

Garduno-Anaya MA Couthino De Toledo H Hinojosa-Gonzalez R Pane-Pianese C Rios-Castaneda LC . Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg. 2005;133(2):285-294.

Chuang-Chuang A Baeza MA . Are intratympanic corticosteroids effective for Ménières disease? Medwave. 2017;17(suppl 1):e6863.

Albu S Nagy A Doros C , et al. Treatment of Ménière’s disease with intratympanic dexamethazone plus high dosage of betahistine. Am J Otolaryngol. 2016;37(3):225-230.

Lambert PR Nguyen S Maxwell KS , et al. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Ménière’s disease. Otol Neurotol. 2012;33(7):1257-1265.

Lambert PR Carey J Mikulec AA LeBel C . Intratympanic sustained-exposure dexamethasone thermosensitive gel for symptoms of Ménière’s disease: randomized phase 2b safety and efficacy trial. Otol Neurotol. 2016;37(10):1669-1676.

Hargunani CA Kempton JB DeGagne JM Trune DR . Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol. 2006;27(4):564-569.

Mynatt R Hale SA Gill RM Plontke SK Salt AN . Demonstration of a longitudinal concentration gradient along scala tympani by sequential sampling of perilymph from the cochlear apex. J Assoc Res Otolaryngol. 2006;7(2):182-193.

Parnes LS Sun AH Freeman DJ . Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109(7, pt 2):1-17.

Salt AN Plontke SK . Pharmacokinetic principles in the inner ear: influence of drug properties on intratympanic applications. Hear Res. 2018;368:28-40.

Doyle KJ Bauch C Battista R , et al. Intratympanic steroid treatment: a review. Otol Neurotol. 2004;25(6):1034-1039.

Morgan AE Ismail EI Ashraf B . Intratympanic injections of dexamethasone in delayed endolymphatic hydrops: a prospective clinical study. ORL J Otorhinolaryngol Relat Spec. 2018;80(1):19-27.

Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Otolaryngol Head Neck Surg. 1995;113(3):179-180.

Salt AN . Pharmacokinetics of drug entry into cochlear fluids. Volta Rev. 2005;105(3):277-298.

Bremer HG van Rooy I Pullens B , et al. Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy—results of a prematurely ended study. Trials. 2014;15:328-328.

Chia SH Gamst AC Anderson JP Harris JP . Intratympanic gentamicin therapy for Ménière’s disease: a meta-analysis. Otol Neurotol. 2004;25(4):544-552.

Huon LK Fang TY Wang PC . Outcomes of intratympanic gentamicin injection to treat Ménière’s disease. Otol Neurotol. 2012;33(5):706-714.

Pullens B van Benthem PP . Intratympanic gentamicin for Ménière’s disease or syndrome. Cochrane Database Syst Rev. 2011;(3):CD008234.

Vlastarakos PV Iacovou E Nikolopoulos TP . Is gentamycin delivery via sustained-release vehicles a safe and effective treatment for refractory Ménière’s disease? A critical analysis of published interventional studies. Eur Arch Otorhinolaryngol. 2017;274(3):1309-1315.

Yetişer S . Intratympanic gentamicin for intractable Ménière’s disease—a review and analysis of audiovestibular impact. Int Arch Otorhinolaryngol. 2018;22(2):190-194.

Cohen-Kerem R Kisilevsky V Einarson TR Kozer E Koren G Rutka JA . Intratympanic gentamicin for Ménière’s disease: a meta-analysis. Laryngoscope. 2004;114(12):2085-2091.

Crane BT Minor LB Della Santina CC Carey JP . Middle ear exploration in patients with Ménière’s disease who have failed outpatient intratympanic gentamicin therapy. Otol Neurotol. 2009;30(5):619-624.

Syed MI Ilan O Leong AC Pothier DD Rutka JA . Ménière’s syndrome or disease: time trends in management and quality of evidence over the last two decades. Otol Neurotol. 2015;36(8):1309-1316.

Nevoux J Barbara M Dornhoffer J Gibson W Kitahara T Darrouzet V . International consensus (ICON) on treatment of Ménière’s disease. Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(1s):S29-s32.

Johnson A Tarima S Wong S Friedland DR Runge CL . Statistical model for prediction of hearing loss in patients receiving cisplatin chemotherapy. JAMA Otolaryngol Head Neck Surg. 2013;139(3):256-264.

Cawthorne T . The surgical treatment of Ménière’s disease. Laryngoscope. 1963;73(8):1016-1021.

Day KM . Labyrinth surgery for Ménière’s disease. Laryngoscope. 1943;53(10):617-630.

Teufert KB Doherty J . Endolymphatic sac shunt, labyrinthectomy, and vestibular nerve section in Ménière’s disease. Otolaryngol Clin North Am. 2010;43(5):1091-1111.

Kemink JL Telian SA Graham MD Joynt L . Transmastoid labyrinthectomy: reliable surgical management of vertigo. Otolaryngol Head Neck Surg. 1989;101(1):5-10.

Langman AW Lindeman RC . Surgery for vertigo in the nonserviceable hearing ear: transmastoid labyrinthectomy or translabyrinthine vestibular nerve section. Laryngoscope. 1993;103(12):1321-1325.

Black FO Effron MZ Burns DS . Diagnosis and management of drop attacks of vestibular origin: Tumarkin’s otolithic crisis. Otolaryngol Head Neck Surg. 1982;90(2):256-262.

Diaz RC LaRouere MJ Bojrab DI Zappia JJ Sargent EW Shaia WT . Quality-of-life assessment of Ménière’s disease patients after surgical labyrinthectomy. Otol Neurotol. 2007;28(1):74-86.

Badke MB Pyle GM Shea T Miedaner J . Outcomes in vestibular ablative procedures. Otol Neurotol. 2002;23(4):504-509.

Pereira KD Kerr AG . Disability after labyrinthectomy. J Laryngol Otol. 1996;110(3):216-218.

Ghossaini SN Wazen JJ . An update on the surgical treatment of Ménière’s diseases. J Am Acad Audiol. 2006;17(1):38-44.

Balkany TJ Sires B Arenberg IK . Bilateral aspects of Ménière’s disease: an underestimated clinical entity. Otolaryngol Clin North Am. 1980;13(4):603-609.

Hammerschlag PE Schuknecht HF . Transcanal labyrinthectomy for intractable vertigo. Arch Otolaryngol. 1981;107(3):152-156.

Doobe G Ernst A Ramalingam R Mittmann P Todt I . Simultaneous labyrinthectomy and cochlear implantation for patients with single-sided Ménière’s disease and profound sensorineural hearing loss. Biomed Res Int. 2015;2015:4.

Hansen MR Gantz BJ Dunn C . Outcomes after cochlear implantation for patients with single-sided deafness, including those with recalcitrant Ménière’s disease. Otol Neurotol. 2013;34(9):1681-1687.

McRackan TR Gifford RH Kahue CN , et al. Cochlear implantation in Ménière’s disease patients. Otol Neurotol. 2014;35(3):421-425.

Hall CD Herdman SJ Whitney SL , et al. Vestibular rehabilitation for peripheral vestibular hypofunction: an evidence-based clinical practice guideline. J Neurol Phys Ther. 2016;40(2):124-155.

McDonnell MN Hillier SL . Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015;1:CD005397.

Glasscock ME 3rd Thedinger BA Cueva RA Jackson CG . An analysis of the retrolabyrinthine vs the retrosigmoid vestibular nerve section. Otolaryngol Head Neck Surg. 1991;104(1):88-95.

Goksu N Yilmaz M Bayramoglu I Bayazit YA . Combined retrosigmoid retrolabyrinthine vestibular nerve section: results of our experience over 10 years. Otol Neurotol. 2005;26(3):481-483.

McKenna MJ Nadol JB Jr Ojemann RG Halpin C . Vestibular neurectomy: retrosigmoid-intracanalicular versus retrolabyrinthine approach. Am J Otol. 1996;17(2):253-258.

Rosenberg SI . Vestibular surgery for Ménière’s disease in the elderly: a review of techniques and indications. Ear Nose Throat J. 1999;78(6):443-446.

Silverstein H Norrell H Rosenberg S . The resurrection of vestibular neurectomy: a 10-year experience with 115 cases. J Neurosurg. 1990;72(4):533-539.

Alarcon AV Hidalgo LO Arevalo RJ Diaz MP . Labyrinthectomy and vestibular neurectomy for intractable vertiginous symptoms. Int Arch Otorhinolaryngol. 2017;21(2):184-190.

Portmann G . The saccus endolymphaticus and an operation for draining for the relief of vertigo. Proc R Soc Med. 1927;20(12):1862-1867.

Schuknecht HF . Myths in neurotology. Am J Otol. 1992;13(2):124-126.

Shambaugh GE Jr Clemis JD Arenberg I . Endolymphatic duct and sac in Ménière’s disease. Arch Otolaryngol. 1969;89(6):816-825.

Gianoli GJ Larouere MJ Kartush JM Wayman J . Sac-vein decompression for intractable Ménière’s disease: two-year treatment results. Otolaryngol Head Neck Surg. 1998;118(1):22-29.

Graham MD Kemink JL . Surgical management of Ménière’s disease with endolymphatic sac decompression by wide bony decompression of the posterior fossa dura: technique and results. Laryngoscope. 1984;94(5, pt 1):680-683.

House WF . Subarachnoid shunt for drainage of hydrops: a report of 63 cases. Arch Otolaryngol. 1964;79:338-354.

Brackmann DE Nissen RL . Ménière’s disease: results of treatment with the endolymphatic subarachnoid shunt compared with the endolymphatic mastoid shunt. Am J Otol. 1987;8(4):275-282.

Arenberg IK Stahle J Wilbrand H Newkirk JB . Unidirectional inner ear valve implant for endolymphatic sac surgery in Ménière’s disease. Arch Otolaryngol. 1978;104(12):694-704.